Literature DB >> 12083449

The value of mass screening for chlamydia control in high prevalence communities.

S Hodgins1, R W Peeling, S Dery, F Bernier, A LaBrecque, J F Proulx, J Joly, M Alary, D Mabey.   

Abstract

The social context and epidemiology of STIs in remote communities in Northern Canada was examined. These communities have a persistently high reported incidence of gonorrhoea and chlamydial infection. They remain in the hyperendemic phase of the N. gonorrhoeae and C. trachomatis epidemics. They are ethnically and culturally homogeneous and contain no readily identifiable core groups, making it impossible to distinguish between spread and maintenance networks. Mass screening of the adult population can reduce the reservoir of C. trachomatis infection under these circumstances. It is particularly important to target men in settings such as this where women are routinely screened in antenatal and family planning clinics.

Entities:  

Mesh:

Year:  2002        PMID: 12083449      PMCID: PMC1765834          DOI: 10.1136/sti.78.suppl_1.i64

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

Review 1.  Screening for genital chlamydia infection.

Authors:  Nicola Low; Shelagh Redmond; Anneli Uusküla; Jan van Bergen; Helen Ward; Berit Andersen; Hannelore Götz
Journal:  Cochrane Database Syst Rev       Date:  2016-09-13

2.  Chlamydia trachomatis prevalence in men in the mid-west of Ireland.

Authors:  J Powell; C O'Connor; M O'hlarlaithe; J Saunders; J De Freitas
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

Review 3.  Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.

Authors:  Shelagh M Redmond; Karin Alexander-Kisslig; Sarah C Woodhall; Ingrid V F van den Broek; Jan van Bergen; Helen Ward; Anneli Uusküla; Björn Herrmann; Berit Andersen; Hannelore M Götz; Otilia Sfetcu; Nicola Low
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

4.  Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk.

Authors:  Ainsley Moore; Gregory Traversy; Donna L Reynolds; John J Riva; Guylène Thériault; Brenda J Wilson; Melissa Subnath; Brett D Thombs
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

5.  Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences.

Authors:  Jennifer Pillay; Aireen Wingert; Tara MacGregor; Michelle Gates; Ben Vandermeer; Lisa Hartling
Journal:  Syst Rev       Date:  2021-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.